Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00055_DB01225_nanopub.RA_YX0XfCWP8v-XFzqvE40Y6y1XSfockxutJ-dGyfdKXM#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00055_DB01225 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00055_DB01225 label "DDI between Drotrecogin alfa and Enoxaparin - Combination should be used with caution after weighing advantages and disadvantages. Low molecular weight heparins such as enoxaparin may increase the adverse effects of drotrecogin. Monitor for bleeding if used concomitantly. [drugbank_resource:DB00055_DB01225]" assertion.
- drugbank_resource:DB00055_DB01225 identifier "drugbank_resource:DB00055_DB01225" assertion.
- drugbank_resource:DB00055_DB01225 title "DDI between Drotrecogin alfa and Enoxaparin - Combination should be used with caution after weighing advantages and disadvantages. Low molecular weight heparins such as enoxaparin may increase the adverse effects of drotrecogin. Monitor for bleeding if used concomitantly." assertion.
- drugbank:DB00055 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00055_DB01225 assertion.
- drugbank:DB01225 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00055_DB01225 assertion.